REQUEST A DEMO
Total
USD $0.00
Search more companies

Cocomed Olga Chmiel sp. k. (Poland)

Main Activities: General Medical and Surgical Hospitals
Full name: Cocomed Olga Chmiel sp. k. Profile Updated: March 10, 2022
Buy our report for this company USD 19.99 Most recent financial data: 2024 Available in: English & Polish Download a sample report

Cocomed Olga Chmiel sp. k. is based in Poland. The head office is in Warsaw. It operates in the General Medical and Surgical Hospitals sector. It was established on February 28, 2022. There was a net sales revenue increase of 8.48% reported in Cocomed Olga Chmiel sp. k.’s latest financial highlights for 2024. There was a total negative growth of 21.94% in Cocomed Olga Chmiel sp. k.’s total assets over the same period. Cocomed Olga Chmiel sp. k.’s net profit margin increased by 291.09% in 2024.

Headquarters
Ul. Bialy Kamien 3 U1
Warsaw; Mazowieckie; Postal Code: 02-593

Contact Details: Purchase the Cocomed Olga Chmiel sp. k. report to view the information.

Basic Information
Financial Auditors:
Purchase the Cocomed Olga Chmiel sp. k. report to view the information.
Incorporation Date:
February 28, 2022
Key Executives
Purchase this report to view the information.
Associate Partner
Purchase this report to view the information.
Limited Partner
Company Performance
Financial values in the chart are available after Cocomed Olga Chmiel sp. k. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency PLN. Absolute financial data is included in the purchased report.
Net sales revenue
8.48%
Total operating revenue
2.57%
Operating profit (EBIT)
15.49%
EBITDA
19.9%
Net Profit (Loss) for the Period
15.49%
Total Assets
-21.94%
Total Equity
-82.81%
Operating Profit Margin (ROS)
291.09%
Net Profit Margin
291.09%
Return on Equity (ROE)
-49.5%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?